DSP Nifty Healthcare Index Fund
Holdings
22
Concentrated
Top 10 weight
78%
Concentration
Strategy
Index
Passive exposure
Equity
100%
Asset allocation
Portfolio
2Sectors
9Large positions
79.8%Top: Pharmaceuticals & Biotechnology
0.0%Cash
Market-cap allocation
Large cap62%
Mid cap36%
Small cap2%
Asset allocation
Equity100%
Top holdings
18.3%
Divi's Laboratories LtdEQUITY
8.9%8.0%
Cipla LtdEQUITY
7.2%7.1%
6.5%
Laurus Labs LtdEQUITY
6.1%6.1%
Lupin LtdEQUITY
5.1%Fortis Healthcare LtdEQUITY
4.3%Aurobindo Pharma LtdEQUITY
3.8%Alkem Laboratories LtdEQUITY
2.9%2.9%
Biocon LtdEQUITY
2.6%Zydus Lifesciences LtdEQUITY
2.5%Mankind Pharma LtdEQUITY
2.4%IPCA Laboratories LtdEQUITY
2.1%Abbott India LtdEQUITY
1.3%Piramal Pharma LtdEQUITY
1.1%0.64%
TREPS / Reverse Repo InvestmentsDERIVATIVE
0.53%Net Receivables/PayablesDERIVATIVE
-0.4%AI Smart summary
Portfolio read
- 100% equity.
- Passive index strategy; portfolio differences should primarily reflect index tracking and cash management.
- Largest equity sector is Pharmaceuticals & Biotechnology at 79.8% of the portfolio.
- Large-cap exposure is 62%.
Watchpoints
- Compact 22-position portfolio; each large position can materially affect returns.
- Top 10 positions account for 78%, indicating high portfolio concentration.
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 80%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Similar index portfolios by equity allocation and concentration.
ICICI Prudential Nifty Healthcare ETF21 holdings · 78% top 10
Aditya Birla Sun Life NIFTY Healthcare ETF22 holdings · 78% top 10
HDFC Nifty50 Value 20 ETF22 holdings · 78% top 10
Kotak Nifty 50 Value 20 ETF21 holdings · 78% top 10
Axis NIFTY Healthcare ETF22 holdings · 78% top 10
ICICI Prudential Nifty50 Value 20 ETF22 holdings · 78% top 10
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
79.8%
20.0%